Adam Cheifetz is the Director of the Center for Inflammatory Bowel Disease, the Medical Director of Infusion Services at Beth Israel Deaconess Medical Center and a Professor of Medicine at Harvard Medical School.
He graduated magna cum laude from Brown University before earning his M.D. from Cornell University Medical College. He completed his internship and residency in Internal Medicine at Yale-New Haven Hospital and his fellowship in Gastroenterology at Yale University before serving as the Present-Levinson
Fellow in Inflammatory Bowel Disease at the Mount Sinai Medical Center in New York City.
He specializes in the treatment of Crohn’s disease, ulcerative colitis, and other inflammatory bowel diseases. In addition to his clinical work, he is involved in multiple research projects relating to IBD. His
research currently focuses on optimizing the use of biologics through the proactive use of drug concentrations and antibodies, and he has published extensively in this area.
Konstantinos Papamichael is an Assistant Professor of Medicine at Beth Israel Deaconess Medical Center.
He received his M.D. and Ph.D. from Medical School, University of Athens, Greece. He completed postdoctoral fellowships at the Medical School, University of Athens, Greece, and at the Department of Clinical and Experimental Medicine, TARGID (Translational Research in Gastro-Intestinal Disorders) and Laboratory for Therapeutic and Diagnostic Antibodies, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Belgium.
He has served as a reviewer for New England Journal of Medicine, Lancet Gastroenterology and Hepatology, Gut, Clinical Gastroenterology and Hepatology, American Journal of Gastroenterology, Journal of Crohn's and Colitis. He has published 140 papers receiving more than 4630 citations and has an h-index of 38 (Google Scholar, 15 November 2023).
